article thumbnail

Leading patient adherence pharmaceutical companies

Pharmaceutical Technology

Failing to adhere to prescribed medication regimens is one of the prime reasons for poor patient health outcomes. Pharmaceutical and healthcare companies are working continuously to improve patient adherence, which also impacts disease control and pharmaceutical industry revenues directly. Patient adherence.

Leads 52
article thumbnail

Beyond the Pill: Creating Value with Patient-Centric Pharmaceutical Marketing

Pharma Marketing Network

The pharmaceutical industry is facing a number of challenges, including increasing competition, rising costs, and changing regulations. In order to succeed in this challenging environment, pharmaceutical companies need to adopt a patient-centric approach to marketing. One way is to use patient-generated content (PGC).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Antibiotic demonstrates non-inferiority to a leading gonorrhoea treatment

European Pharmaceutical Review

percent success rates in patients with uncomplicated urogenital gonorrhoea (GC). The company noted that the duration for patients was approximately 28 days in both trials. The post Antibiotic demonstrates non-inferiority to a leading gonorrhoea treatment appeared first on European Pharmaceutical Review.

Leads 103
article thumbnail

Putting Patients First: Improving the Pharmaceutical Supply Chain

Impetus Digital

The pharmaceutical supply chain can be a difficult and demanding system to manage. Medications and supplies must be handled with the utmost care, often needing to comply with strict temperature regulations and changing demands from patients and providers that vary depending on the country.

article thumbnail

Theseus Pharma Lays Off Staff, Explores Options Months After Toxicity Scuttles Lead Drug

MedCity News

Theseus Pharmaceuticals discontinued its former lead program in July following the report of dose-limiting toxicities in two patients. Though Theseus has other assets in its pipeline, it has decided to explore strategic alternatives with the goal of “maximizing shareholder value.”

Leads 111
article thumbnail

Leading payers in the pharmaceutical industry

Pharmaceutical Technology

Factors such as increasing access to health information, the introduction of new medical treatments and technologies and the spike in birth rate are increasing the need for payers in the pharmaceutical industry. Payers ensure the delivery of the best possible health outcomes to the patients from their financial plan. Pricing research.

Leads 59
article thumbnail

FDA Reconsideration Leads to Approval of Takeda Drug for Rare Esophagus Disorder

MedCity News

FDA approval of Takeda Pharmaceutical drug Eohilia introduces a new therapeutic option for patients with eosinophilic esophagitis, inflammation of the esophagus that causes swallowing difficulty. It will compete against Dupixent, a Sanofi and Regeneron Pharmaceuticals drug already approved for this disorder.

FDA 114